Our core R&D facility, based in Plymouth, MI, is comprised of some of the best scientific minds in academia and research.
Dr. Peterson has nearly 30 years of scientific research expertise and has participated in ground-breaking clinical oncology research. He was one of the team members to discover an alternative splice variant associated with the t(8;21) translocation that promotes acute myeloid leukemia. He was involved in early clinical development of an MDM2 inhibitor for the treatment of chronic myeloid leukemia and involved in the discovery of a deubiquitinase-inhibitor for the treatment of myeloma, melanoma and pancreatic cancer.
University of California, Irvine
Albany Medical College